Interaction of radiation and etoposide on two cell lines with different radiosensitivities in vitro

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3459-3464

  Takahashi, Takeo ^a,c   Mitsuhashi, Norio ^b   Akimoto, Tetsuo ^c   Matsumoto, Hiroko ^c   Ishikawa, Hitoshi ^c   Saito, Yoshihiro ^c   Niibe, Hideo ^c  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Etoposide; Radiation; Radiosensitivity; Rat yolk sac tumor cell line

Indexed keywords

DNA FRAGMENT; ETOPOSIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG SENSITIVITY; EVALUATION; IN VITRO STUDY; INCIDENCE; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; RAT; SURVIVAL RATE; TUMOR CELL LINE; YOLK SAC TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG ADMINISTRATION SCHEDULE; ENDODERMAL SINUS TUMOR; ETOPOSIDE; RADIATION TOLERANCE; RATS; TUMOR CELLS, CULTURED;

EID: 0042028354     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ross W, Rowe T, Glisson B, Yalowich J and Liu L: Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res 44: 5857-5860, 1984.
2. Matsuura M, Hasegawa M, Niibe H et al: Experimental study of the effects on apoptosis of docetaxel alone and in combination with irradiation. Oncol Rep 7: 289-293, 2000.
3. Mitsuhashi N, Takahashi T, Nozaki M, Matsumoto H, Sakurai H, Takahashi M and Niibe H: Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential lymphatic metastasis. Jpn J Cancer Res 84: 1287-1291, 1993.
4. Mitsuhashi N, Takahashi T, Sakurai H, Nozaki M, Akimoto T, Hasegawa M, Saito Y, Matsumoto H, Higuchi K, Maebayashi K and Niibe H: A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumor cell line, NMT-1: differences of early radiation -induced morphological changes, especially apoptosis. Int J Radiat Biol 69: 329-336, 1996.
5. Nakamoto S, Mitsuhashi N, Takahashi T, Sakurai H and Niibe H: An interaction of cisplatin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Int J Radiat Biol 70: 747-753, 1996.
6. Kubota N, Ikegami T, Watai K et al: Effect of combined treatment of HeLa S3 cells with radiation and Etoposide on cell survival. Nippon Acta Radiol 48: 1276-1282, 1988.
7. Saito T, Shimada Y, Kawanori J et al: The suppressive effect of etoposide on recovery from sublethal radiation damage in Chinese hamster V79 cells. J Jpn Soc Ther Radiol Oncol 4: 123-130, 1992.
8. Shigematsu N, Kawata T, Ihara N, Kawaguchi O et al: Effect of combined treatment with radiation and low dose etoposide on cell survival. Anticancer Res 21: 325-328, 2001.
9. Skov K, Zhou H and Marples B: The effect of two topoisomerase inhibitors on low-dose hypersensitivity and increased radioresistance in Chinese Hamster V79, cells. Radiation Res 138: S117-S120, 1994.
10. Giocanti N, Hennequin C, Balosso, J, Mahler M and Favaudon V: DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide. Cancer Res 53: 2105-2111, 1993.
11. Stephens LC, Ang KK, Schultheiss TE, Milas L and Meyn RE: Apoptosis in irradiated murine tumors. Radiation Res 127: 308-316, 1991.
12. Ling CC, Chen CH and Li WX: Apoptosis induced at different dose rates: implication for the shoulder region of cell survival curves. Radiother Oncol 32: 129-136, 1994.
13. Arends MJ and Wyllie AH: Apoptosis: mechanism and roles in pathology. Int Rev Exp Pathol 32: 223-254, 1991.
14. Crooilimans RPMA, Schwachofer JMH and Hoogenhout J: The influence of pre-irradiation on the survival of two head and neck squamous cell carcinoma cell line. Anticancer Res 11: 297-300, 1991.
15. Hill BT: Interaction between anticancer agents and radiation and the expression of resistance. Cancer Treatment Reviews 18: 149-190, 1991.
16. Redpath JL, Hyden EC and Sun C: Induction of cisplatinum sensitivity without alteration in radiation sensitivity by fractionated radiation treatment of a human laryngeal squamous cell carcinoma cell line. Int J Radiat Oncol Biol Phys 32: 681-685, 1995.
17. Haddock MG, Ames MM and Bonner JA: Assessing the interaction of irradiation with etoposide or idarubicin. Mayo Clin Proc 70: 1053-1060, 1995.
18. Blagosklonny MV and El-Deiry WS: Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Int J Cancer 75: 933-940, 1998.
19. Matsubara H, Kimura M, Sugaya M et al: Expression of wild type p53 gene confers increased sensitivity to radiation and chemotherapeutic agent in human esophageal carcinoma cells. J Oncology 14: 1081-1085, 1999.
20. Wu GS and El-Deiry WS: Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or Bcl-2. Clin Cancer Res 2: 623-633, 1996.
21. Arita D, Kambe M, Ishikawa C and Kanamaru R: Induction of p53-independent apoptosis associated with G2M arrest following DNA damage in human colon cancer cell lines. Jpn J Cancer Res 88(1): 39-43, 1997.
22. Kao GD, McKenna WG and Yen TJ: Detection of repair activity the DNA damage-induced G2 delay in human cancer cells. Oncogene 20: 3486-3496, 2001.
23. Maebayashi K, Mitsuhashi N, Takahashi T, Sakurai H and Niibe H: p53 mutation decreased radiosensitivity in rat yolk sac tumor cell lines. Int J Radiat Oncol Biol Phys 44: 677-682, 1999.